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1. INTRODUCTION
Recreational use of cathinone-derived synthetic stimulants, more commonly known as “bath
salts”, has increased in prevalence during the last five years. Of these, mephedrone (4-
methylmethcathinone or “meow-meow”) is popular among recreational users, most likely
due to its availability and ability to elevate mood and produce euphoria [1]. Mephedrone use
is associated with several stimulant-like drug effects, including increased concentration,
talkativeness, psychomotor stimulation, reduced appetite, and insomnia [1]. Recent studies
have described compulsive drug taking [2], and several deaths have been attributed to
mephedrone use [3]. Not surprisingly, several countries, including the United States, have
recently banned the production, possession, and sale of mephedrone and other cathinone
derivatives [4].
Activation of mesocorticolimbic dopamine circuits is a common effect of drugs of abuse,
and these circuits play a critical role in motivated behaviors, drug reinforcement, and drug
seeking [5]. The effects of drugs of abuse on these circuits can be modeled in laboratory
animals using several behavioral conditioning techniques, including intracranial self-
stimulation (ICSS) [6, 7]. ICSS measures the effects of drugs on operant responding for
electrical stimulation of several brain regions, particularly the medial forebrain bundle
(MFB). The MFB carries ascending dopaminergic projections from the ventral tegmental
area (VTA) to targets in the nucleus accumbens (NAc) and prefrontal cortex (PFC), as well
as descending glutamatergic and GABAergic fibers to the midbrain [5]. Stimulation of the
MFB is potently reinforcing [8] and enhances dopamine release in terminal fields [9]. Drugs
of abuse, especially psychomotor stimulants, reduce the amount of stimulation required to
sustain responding, as measured by the stimulation frequency that supports half-maximal
responding (EF50) or the brain stimulation reward (BSR) threshold, θ0 [7, 10, 11].
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In these studies, we investigated the behavioral effects of mephedrone in C57BL/6J mice
using ICSS. While previous studies have examined mephedrone pharmacology and patterns
of misuse in human populations (reviewed in [12]), the behavioral effects of mephedrone
have been largely unexplored in rodents. BSR threshold, EF50, and maximum response rates
were determined in C57BL/6J mice before and after treatment with mephedrone, cocaine, or
saline vehicle to test the hypothesis that mephedrone would potentiate brain stimulation
reward similarly to the psychostimulant cocaine.
2. MATERIALS AND METHODS
2.1. Mice
Male C57BL/6J mice (n = 6; Jackson Laboratories, Bar Harbor, ME) weighing at least 25 g
were housed individually in polycarbonate cages (28 × 17 × 14 cm) with food and water
freely available through wire lids. Cob-bedding was changed weekly, and the vivarium was
21°C with a 12 hour light cycle (lights on at 8:00 PM). Procedures, approved by the
University of North Carolina Institutional Animal Care and Use Committee (IACUC), were
conducted according to the Guide for the Care and Use of Laboratory Animals (NIH
publication No. 85-23, revised 2011) between 8:30 AM and 12:30 PM.
2.2. Surgery
Under ketamine (120 mg/kg) and xylazine (18 mg/kg) (Sigma, St Louis, MO) anesthesia,
mice were stereotaxically implanted with insulated monopolar stainless steel electrodes
(0.28 mm diameter, Plastics One, Roanoke, VA) aimed at the right medial forebrain bundle
at the level of the lateral hypothalamus (coordinates relative to bregma: AP -1.2 mm, ML
-1.0 mm, DV -5.0 mm) [13], grounded to a stainless steel skull screw and secured to the
skull with dental cement.
2.3. Intracranial Self-Stimulation
ICSS experiments were performed as previously described [14, 15] in sound-attenuating
chambers (16 × 14 × 13 in, MedAssociates, St Albans, VT) containing operant conditioning
boxes with a grid floor (ENV-005A; MedAssociates), wheel manipulandum (ENV-113AM;
MedAssociates) and house light (ENV-315W; MedAssociates). MED-PC software for
Windows (v4.1; MedAssociates) controlled electrical stimulation (500 ms train of unipolar
cathodal square-wave current 100 μs pulses and a trial-dependent frequency) through a
stimulator (PHM-150B/2; MedAssociates) connected to a swivel commutator and insulated
wire (Plastics One, Roanoke, VA) attached to the stimulating electrode. Each response (1
response = ¼ turn of the wheel manipulandum) activated the house light and produced a
stimulation. During the 500 ms stimulation period, wheel responses were recorded but did
not earn additional stimulation.
Mice were initially conditioned to respond for brain stimulation reward (BSR) at a single
stimulus intensity and frequency, after which stimulus intensity remained constant for each
mouse. Mice were subsequently trained to respond for 15 decreasing stimulation frequencies
(0.05 log10 steps) presented in three series. Each frequency was available for 50 seconds and
separated by a 10-second timeout in which 5 non-contingent priming stimulations were
delivered. For each response series, the maximum response rate was measured, and the
frequency that maintains half-maximal responding (EF50) and sustains responding (BSR
threshold or θ0) were estimated through least squares regression. Daily baseline values were
calculated from responses during the second and third series. When ICSS responding was
stabilized, the mice were tested for the effects of mephedrone (1.0, 3.0, 10.0 mg/kg or saline
i.p.) or cocaine (1.0, 3.0, 10.0 mg/kg or saline i.p.). After baseline responding, the mice were
removed from the conditioning chambers, injected with drug, and returned immediately for
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four 15-minute response series (i.e. 60 minutes of testing). Post-injection ICSS measures
were expressed as a percentage of the pre-injection baseline on that day.
2.4. Histology
At the end of the experiment, 50 μm coronal brain sections were collected from each mouse
following anesthesia with sodium pentobarbital (120 mg/kg i.p.) and intracardiac perfusion
with 0.9% saline followed by 4% paraformaldehyde in 0.1 M phosphate buffered saline.
Sections were stained with cresyl violet for Nissl, and electrode locations were confirmed by
direct microscopic visualization. One mouse died before the end of the study, and electrode
placements were unavailable for this subject.
2.5. Drugs
Mephedrone (4-methylmethcathinone; generously provided by Dr. Michael Taffe, Scripps
Research Institute, La Jolla, CA) and cocaine (Sigma) were dissolved in 0.9% saline and
injected intraperitoneally through a 27-gauge needle in a volume of 1ml/100g body weight.
Drug doses were given in a random order that alternated every other day with saline
injections. Each drug dose was given twice and its effects on ICSS measures were averaged
for each mouse. Only behavioral data from mice that received all drug doses were included
in analyses of each drug effect. All experiments involving mephedrone were performed prior
to scheduling by the United States Drug Enforcement Agency on October 21, 2011.
2.6. Data Analysis
One-way repeated measures analysis of variance (ANOVA) determined the effects of
mephedrone and cocaine on measures of ICSS. Bonferroni-corrected post hocs were
performed when p < 0.05. Paired t-tests were used to compare repeated treatments for each
drug dose and response series
3. RESULTS
The electrode placements are shown in Figure 1A-B. All 6 mice that were implanted
responded for electrical stimulation of the medial forebrain bundle within 2 sessions.
Although electrodes were implanted at the AP (skull, relative to bregma) coordinate of -1.3
mm, tip locations varied from -1.06 to -1.58 mm. The average baseline EF50 and response
threshold (θ0) in these mice prior to all drug experiments expressed as charge delivery was
-0.31 ±0.028 μC and -0.36 ±0.036 μC, respectively. The average baseline maximum
response rate prior to all drug experiments was 162 ± 20.6 responses/50s. The mice
responded in a frequency-dependent manner, and mephedrone and cocaine produced parallel
leftward shifts the rate-frequency curves, despite having different effects on maximum
response rate (Figure 1C). No significant differences were detected between drug replicates
for each drug, dose, and response series.
Mephedrone dose-dependently lowered EF50 (Figure 2) and BSR threshold (θ0; Figure 3)
during the second (F3,15 = 19.0, p < 0.001; F3,15 = 7.4, p = 0.003, respectively), third (F3,15
= 5.4, p = 0.01; F3,15 = 3.7, p = 0.04, respectively), and fourth (F3,15 = 12.6, p < 0.001; F3,15
= 3.7, p = 0.03, respectively) 15-minute post-injection response series when compared to
saline vehicle. There was no significant effect on responding during the first 15-minutes of
testing. Post hoc analysis revealed that the 3.0 mg/kg (i.p.) mephedrone dose significantly
lowered EF50 during the second 15-minute post-injection response series, while the 10.0
mg/kg dose (i.p.) significantly lowered EF50 during the second, third, and fourth response
series. The 3.0 and 10.0 mg/kg (i.p.) mephedrone dose significantly lowered θ0 during the
second 15-minute post-injection response series.
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Cocaine dose-dependently lowered EF50 (Figure 2) and BSR threshold (θ0; Figure 3) during
the first 15-minute post-injection response series when compared to saline (F3,12 = 7.1, p =
0.005; F3,12 = 6.3, p = 0.008, respectively). Cocaine lowered the EF50, but not BSR
threshold, during the second (F3,12 = 9.0, p = 0.002) and third (F3,12 = 7.4, p = 0.006) 15-
minute post-injection response series when compared to saline. These doses did not
significantly affect responding during the final 15 minutes of testing. Post hoc analysis
revealed that the 3.0 mg/kg (i.p.) cocaine dose significantly lowered EF50 during the first
and second 15-minute post injection series when compared to saline vehicle. The 10.0 mg/
kg (i.p.) cocaine dose significantly lowered EF50 during the first, second, and third response
series and lowered the BSR threshold in the first series only.
Mephedrone dose-dependently lowered maximum response rate (Figure 4) during the
second 15-minute post-injection response series (F3,15 = 6.8, p = 0.004); only the 10.0 mg/
kg dose was significantly different from the saline vehicle. Cocaine tended to increase
maximum response rate in the first 15-minute response period, but this effect was not
significant (Figure 4).
4. DISCUSSION
The intracranial self-stimulation (ICSS) method has been used since the 1950's to
characterize brain reward system function in rodents [5]. Drugs with abuse potential,
regardless of their pharmacological class, potentiate brain stimulation reward (BSR) [7].
Using ICSS, we examined the behavioral effects of the synthetic stimulant mephedrone in
C57BL/6J mice and compared them to cocaine. We found that across the dose range tested
(1.0, 3.0, and 10.0 mg/kg i.p.), cocaine and mephedrone both lowered EF50 and θ0 with
similar potency. Mephedrone also decreased maximum response rate during the second 15-
minute response series, while cocaine produced a non-significant trend toward increased
maximum response rate during the first 15 minutes of testing. Although the behavioral
effects of mephedrone were detected 15 minutes after the effects of cocaine, the duration of
action of each drug on measures of ICSS was similar.
In these studies, we used the “curve-shift” method of ICSS to test the behavioral effects of
mephedrone and cocaine on brain reward circuitry. During each testing session, mice
responded for descending frequencies of brain stimulation, generating characteristic rate-
frequency curves. Drugs that potentiate BSR produce a leftward shift in the rate-frequency
curve (e.g. cocaine [14]), as evidenced by decreases in the EF50 and θ0. Drugs that devalue
BSR (e.g. neuroleptics [16]), produce a rightward shift in the rate-frequency curve and
increase the EF50 and θ0. Since drugs are given non-contingently in ICSS, one can use this
method to quantify the behavioral effects of a substance on mesocorticolimbic reward
circuitry independent of drug consumption. In these experiments, both cocaine and
mephedrone produced robust parallel leftward shifts in the rate frequency curve (e.g. Figure
1C), and the magnitude of these effects on EF50 and θ0 was similar for both drugs. The
maximum effect of the 10.0 mg/kg cocaine dose on EF50 and θ0 was (66.4 ± 9.4%; 60.1 ±
12.7% of pre-injection baseline, respectively), while the maximum effect of 10.0 mg/kg
mephedrone dose on EF50 and θ0 was (72.3 ± 5.8%; 59.6 ± 10.9% of pre-injection baseline,
respectively). These results suggest that mephedrone potentiates responding for BSR in
C57BL/6J mice similarly to cocaine, which may be indicative of its abuse potential.
Mesocorticolimbic dopamine pathways are a common substrate of drugs of abuse, and
involve neurotransmitter release in cortical and subcortical areas, such as the NAc and PFC,
by A10 projection neurons in the midbrain VTA. Activation of these pathways is thought to
motivate and reinforce drug taking [17]. Mephedrone administration robustly increases
activity in the NAc, PFC, and VTA, as measured by c-Fos expression [18], and increases
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extracellular levels of dopamine (DA; 498%) and serotonin (5-HT; 941%) in the NAc of
awake rats [19]. These effects are most likely due to transporter-mediated efflux of
monoamines [20], rather than by re-uptake inhibition, which is the sole mechanism of action
of cocaine [21]. Mephedrone displays nanomolar potency for the dopamine transporter
(DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) and is similar
to 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) in selectivity and potency
[20]. In ICSS, drugs that enhance dopaminergic neurotransmission lower response
thresholds [16], while serotoninergic agents have diverse effects on ICSS responding
depending on the receptor subclass they target [22]. For example, 5-HT1A receptor agonists
lower thresholds [23], while 5-HT1B agonists [24], 5-HT2C agonists [25], and the selective
serotonin re-uptake inhibitor fluoxetine [23] increase thresholds. MDMA, which produces
similar elevations of extracellular DA and 5-HT as mephedrone [19, 20], robustly lowers
ICSS thresholds in rats [26]. Although mechanisms underlying the observed effects of
mephedrone in these studies are unknown, the enhancement of dopaminergic, as well as
serotonergic, neurotransmission in loci associated with positive reinforcement (e.g. NAc)
may contribute to the potentiation of BSR by the drug. Future studies using
electrophysiological or voltammetric techniques would be required to support this
hypothesis.
To date, there have been only a few studies examining the effects of mephedrone on
substance abuse-related behaviors in animal models. These methods include drug self-
administration, in which a drug reinforces operant responding, and the conditioned place
preference method (CPP), a variant of Pavlovian conditioning in which laboratory animals
display preference for previously drug-paired environments. For example, the
psychostimulant cocaine, as well as methamphetamine [27] and amphetamine [28], is
readily self-administered by C57BL/6J mice [27] and produces robust conditioned place
preference [29]. Although the behavioral effects of mephedrone have not been investigated
in mice using these methods, the drug is intravenously self-administered by Sprague-Dawley
rats using a fixed-ratio reinforcement schedule [30]. In planaria, mephedrone induces place
preference and causes abstinence-induced withdrawal-like behavior [31]. The current
findings, when examined in the context of other behavioral effects of the drug, suggest that
mephedrone is a potent reinforcer that requires further behavioral characterization in animal
models of drug abuse.
We also observed that mephedrone dose-dependently decreased maximum response rate
during the second 15 minutes of testing, while cocaine produced a non-significant trend
toward increased maximum response rate during the first 15-minute response period, which
has been previously reported in C57BL/6J mice [14]. The curve-shift ICSS method is rate-
dependent, and therefore maximum response rate provides some information about the
psychomotor effects of the drug tested [10, 32]. It is unlikely that the effects of mephedrone
on maximum response rate were due to sedation, however, given that it produces locomotor
stimulation in rats [18, 20] and mice [33]. Alternatively, mephedrone may have induced
behaviors that interfered with operant responding, such as stereotypies, which are observed
following MDMA exposure [34]. Most likely, divergent effects of cocaine and mephedrone
on maximum operant response rate reflect differences in their mechanism of action. Unlike
the monoamine re-uptake inhibitor cocaine, mephedrone produces a robust transporter-
mediated increase in striatal 5-HT levels [19, 20], which is associated with reduced ICSS
response rate (e.g. following fenfluramine administration [35]). Given that selective DAT
blockade by GBR-12909 enhances responding for BSR [36], the effects of cocaine on
maximum response rate are likely due to its effects on extracellular dopamine levels. Future
studies that further characterize the psychomotor effects of mephedrone in the context of
dopaminergic and serotonergic neurotransmission may help explain the observed effect of
mephedrone on maximum response rate.
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Recreational use of “bath salts” has increased in recent years, and stimulant abuse represents
a significant public health problem. These substances are associated with compulsive drug
taking and have dangerous side effects (e.g. neurotoxicity, hyperthermia, seizures, etc.). As
of October 21, 2011, mephedrone was temporarily assigned Schedule I status for one year
by the United States Drug Enforcement Agency while the United States Department of
Health and Human Services investigates whether it should be permanently controlled under
the Controlled Substances Act. Schedule I status denotes substances that have a high
potential for abuse without having a legitimate therapeutic use [4]. This study examined the
ability of acutely administered cocaine and mephedrone to alter responding for electrical
stimulation of the medial forebrain bundle using the curve-shift method of ICSS in C57BL/
6J mice. We demonstrate that mephedrone, like cocaine and amphetamines, potentiates
brain stimulation reward, which may indicate that it has a high potential for abuse. Future
studies will be necessary to fully characterize the cellular and behavioral effects of acute and
chronic mephedrone exposure and compare them to more extensively characterized
psychostimulants.
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• Mephedrone and cocaine similarly affected ICSS responding in C57BL/6J mice.
• Both drugs decreased the EF50 and BSR threshold (θ0).
• 10.0 mg/kg mephedrone (i.p.) lowered maximum operant response rate.
• Mephedrone had a slower onset of action than cocaine.
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Placement of intracranial self-stimulation monopolar electrodes (Panels A-B) and
representative rate-frequency curves (Panel C) in C57BL/6J mice. Electrodes were aimed at
the right medial forebrain bundle at the level of the lateral hypothalamus. Black circles
represent the most ventral position of the electrode tip (Panel A) as detected by visual
inspection of Nissl stained brain sections using light microscopy (Panel B). Panel C depicts
responding for different frequencies of brain stimulation reward by an individual C57BL/6J
mouse. These rate-frequency curves depict the effects of saline vehicle (i.p.; white circles),
10.0 mg/kg cocaine (i.p.; black circles), and 10.0 mg/kg mephedrone (i.p.; gray triangles)
during the first (0 – 15 min) and second (16 – 30) post-injection response period following a
baseline determination (white diamonds).
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Dose-response relationship for the effects of mephedrone and cocaine on the frequency that
supported half-maximal responding (EF50) in C57BL/6J mice. EF50 was measured before
and after intraperitoneal injection with saline vehicle (white symbols), mephedrone (1.0, 3.0,
and 10.0 mg/kg, i.p.; gray triangles; n = 6), or cocaine (1.0, 3.0, and 10.0 mg/kg, i.p.; black
circles; n = 5). Results are presented as mean percentage of pre-injection baseline during
four 15-minute post-injection response series (0-15, 16-33, 31-45, and 46-60 minutes post-
injection) ± S.E.M. Asterisks indicate significance (p < 0.05) vs. saline vehicle.
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Dose-response relationship for the effects of mephedrone and cocaine on the brain
stimulation reward threshold (θ0) in C57BL/6J mice. θ0 was measured before and after
intraperitoneal injection with saline vehicle (white symbols), mephedrone (1.0, 3.0, and 10.0
mg/kg, i.p.; gray triangles; n = 6), or cocaine (1.0, 3.0, and 10.0 mg/kg, i.p.; black circles; n
= 5). Results are presented as mean percentage of pre-injection baseline during four 15-
minute post-injection response series (0-15, 16-33, 31-45, and 46-60 minutes post-injection)
± S.E.M. Asterisks indicate significance (p < 0.05) vs. saline vehicle.
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Dose-response relationship for the effects of mephedrone and cocaine on the maximum
response rate (MAX) in C57BL/6J mice. Maximum response rate was measured before and
after intraperitoneal injection with saline vehicle (white symbols), mephedrone (1.0, 3.0, and
10.0 mg/kg, i.p.; gray triangles; n = 6), or cocaine (1.0, 3.0, and 10.0 mg/kg, i.p.; black
circles; n = 5). Results are presented as mean percentage of pre-injection baseline during
four 15-minute post-injection response series (0-15, 16-33, 31-45, and 46-60 minutes post-
injection) ± S.E.M. Asterisks indicate significance (p < 0.05) vs. saline vehicle.
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